Funding for this research was provided by:
National Research Foundation of Korea (NRF-2020M3E5E2037430, 2019M3A9A8065574)
Chong Kun Dang Pharmaceutical
Korea Health Industry Development Institute (HI14C1277)
Deutsche Forschungsgemeinschaft (FOR2722)
Received: 29 January 2021
Accepted: 23 June 2021
First Online: 5 July 2021
: The human study was approved by the Institutional Review Board (IRB No. 1603-141-751). The study was performed in accordance with the Declaration of Helsinki. The animal study was reviewed and approved by the CKD Institutional Animal Care and Use Committee (approval No. S-16-038).
: Not applicable.
: The authors declare that they have no competing interests.